Amicus Therapeutics: 2Q Earnings Snapshot
CRANBURY, N.J. (AP) _ Amicus Therapeutics Inc. (FOLD) on Thursday reported a loss of $84.6 million in its second quarter.
On a per-share basis, the Cranbury, New Jersey-based company said it had a loss of 36 cents. Losses, adjusted for non-recurring costs, were 34 cents per share.
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for a loss of 34 cents per share.
The pharmaceutical company posted revenue of $44.1 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $41.1 million.
Amicus Therapeutics shares have increased 23% since the beginning of the year. The stock has dropped 24% in the last 12 months.